Summary: In an opinion piece for Baltimore Sun, Monnica Williams, Ph.D., and Morgan Campbell, M.D., provide a compelling argument for expediting access to psychedelic-assisted therapy, including MDMA-assisted therapy in the treatment of PTSD.
“There is special injustice in the psychiatric establishment denying these medications to stigmatized populations,” the authors explain, comparing the limited access of psychedelic therapies today to that of experimental treatments for AIDS in the 1980s.
Originally appearing here.